0001209191-18-005235.txt : 20180124 0001209191-18-005235.hdr.sgml : 20180124 20180124185244 ACCESSION NUMBER: 0001209191-18-005235 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180124 FILED AS OF DATE: 20180124 DATE AS OF CHANGE: 20180124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Whitcup Scott M CENTRAL INDEX KEY: 0001298941 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38356 FILM NUMBER: 18546332 MAIL ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Menlo Therapeutics, Inc. CENTRAL INDEX KEY: 0001566044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453757789 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4085 CAMPBELL AVENUE, SUITE 200 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-486-1416 MAIL ADDRESS: STREET 1: 4085 CAMPBELL AVENUE, SUITE 200 CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: Tigercat Pharma, Inc. DATE OF NAME CHANGE: 20130104 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2018-01-24 0 0001566044 Menlo Therapeutics, Inc. MNLO 0001298941 Whitcup Scott M 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 1 0 0 0 Stock Option 1.83 2026-02-02 Common Stock 121964 D Stock Option 4.83 2027-08-24 Common Stock 14635 D The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly. Reflects a 1-for-2.6975 reverse stock split of the Issuer's capital stock effected on January 8, 2018. /s/ Stephen Thau as attorney-in-fact 2018-01-24 EX-24 2 attachment1.htm EX-24 DOCUMENT

POWER OF ATTORNEY

        Known all by these present, that the undersigned hereby constitutes and
appoints each of Steven Basta, Kristine Ball and Stephen Thau, with full power
of substitution, the undersigned's true and lawful attorney-in-fact to:

(1)     prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") an
Update Passphrase Acknowledgement and any other forms necessary to generate new
EDGAR codes on my behalf enabling the undersigned to make electronic filings
with the SEC of reports required by Section 16(a) of the Securities Exchange Act
of 1934 or any rule or regulation of the SEC;

(2)     execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director and/or more than 10% stockholder of Menlo
Therapeutics Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section
16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(3)     do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3, 4,
or 5, complete and execute any amendment or amendments thereto, and timely file
such form with the SEC and any stock exchange or similar authority; and

(4)     take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney- in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.

        The undersigned hereby grants such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys in fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of January 24, 2018.


Signature:  /s/ Scott Whitcup
Print Name: Scott Whitcup